妇产科指南

订阅

MedSci主页 / 所有栏目 / 妇产科指南

2020 SMFM咨询系列#50：限制活动在产科管理中的应用

2020-08-01 母胎医学会 Am J Obstet Gynecol . 2020 Aug;223(2):B2-B10.

产科

2020年8月，母胎医学会(SMFM)发布了限制活动在产科管理中的应用建议，用以替代2014年8月份的33号文件。经目前建议反对应用限制活动，但在多种临床情况下，限制活动仍是预防早产的常见干预措施。妊

中文标题：

2020 SMFM咨询系列#50：限制活动在产科管理中的应用

英文标题：

Society for Maternal-Fetal Medicine Consult Series #50: The role of activity restriction in obstetric management

发布机构：

母胎医学会

发布日期：

2020-08-01

简要介绍：

2020年8月，母胎医学会(SMFM)发布了限制活动在产科管理中的应用建议，用以替代2014年8月份的33号文件。经目前建议反对应用限制活动，但在多种临床情况下，限制活动仍是预防早产的常见干预措施。妊娠高血压、早产胎膜早破、多胎妊娠、阴道出血、宫颈短、前置胎盘和胎儿生长受限常常会建议限制活动。本文主要针对限制活动在产科管理中的应用提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 SMFM咨询系列#50：限制活动在产科管理中的应用.pdf)] GetToolGuiderByIdResponse(projectId=1, id=fff6b1c001981863, title=2020 SMFM咨询系列#50：限制活动在产科管理中的应用, enTitle=Society for Maternal-Fetal Medicine Consult Series #50: The role of activity restriction in obstetric management, guiderFrom=Am J Obstet Gynecol . 2020 Aug;223(2):B2-B10., authorId=0, author=, summary=2020年8月，母胎医学会(SMFM)发布了限制活动在产科管理中的应用建议，用以替代2014年8月份的33号文件。经目前建议反对应用限制活动，但在多种临床情况下，限制活动仍是预防早产的常见干预措施。妊, cover=https://img.medsci.cn/2020930/1601476369681_2020535.jpg, journalId=0, articlesId=null, associationId=951, associationName=母胎医学会, associationIntro=null, copyright=0, guiderPublishedTime=Sat Aug 01 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月，母胎医学会(SMFM)发布了限制活动在产科管理中的应用建议，用以替代2014年8月份的33号文件。经目前建议反对应用限制活动，但在多种临床情况下，限制活动仍是预防早产的常见干预措施。妊娠高血压、早产胎膜早破、多胎妊娠、阴道出血、宫颈短、前置胎盘和胎儿生长受限常常会建议限制活动。本文主要针对限制活动在产科管理中的应用提供指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=11369, tagName=产科)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=11369, guiderKeyword=产科, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1791, appHits=82, showAppHits=0, pcHits=549, showPcHits=1709, likes=0, shares=5, comments=10, approvalStatus=1, publishedTime=Wed Sep 30 23:43:29 CST 2020, publishedTimeString=2020-08-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Sep 30 22:32:59 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 00:37:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 SMFM咨询系列#50：限制活动在产科管理中的应用.pdf)])
2020 SMFM咨询系列#50：限制活动在产科管理中的应用.pdf
下载请点击：
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1058002, encodeId=ead1105800209, content=学习收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb85598371, createdName=henghengbobo, createdTime=Wed Oct 06 00:53:36 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927028, encodeId=a5af92e02879, content=谢谢分享，很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=39831709355, createdName=秋敏, createdTime=Thu Feb 25 08:52:49 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911032, encodeId=f403911032af, content=临床指导意义重大！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a195447725, createdName=ms9000000471094618, createdTime=Sat Dec 26 09:46:05 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904499, encodeId=33e79044997b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:36:57 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903059, encodeId=322590305925, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201128/8bd43ecc40d747e890c41c35a068882e/9f274b8360b04bf085fc42125c37f102.jpg, createdBy=c4bc5437608, createdName=ms1000001333439432, createdTime=Sat Nov 28 16:18:25 CST 2020, time=2020-11-28, status=1, ipAttribution=)]
    2021-10-06 henghengbobo

    学习收藏

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1058002, encodeId=ead1105800209, content=学习收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb85598371, createdName=henghengbobo, createdTime=Wed Oct 06 00:53:36 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927028, encodeId=a5af92e02879, content=谢谢分享，很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=39831709355, createdName=秋敏, createdTime=Thu Feb 25 08:52:49 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911032, encodeId=f403911032af, content=临床指导意义重大！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a195447725, createdName=ms9000000471094618, createdTime=Sat Dec 26 09:46:05 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904499, encodeId=33e79044997b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:36:57 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903059, encodeId=322590305925, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201128/8bd43ecc40d747e890c41c35a068882e/9f274b8360b04bf085fc42125c37f102.jpg, createdBy=c4bc5437608, createdName=ms1000001333439432, createdTime=Sat Nov 28 16:18:25 CST 2020, time=2020-11-28, status=1, ipAttribution=)]
    2021-02-25 秋敏

    谢谢分享，很棒

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1058002, encodeId=ead1105800209, content=学习收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb85598371, createdName=henghengbobo, createdTime=Wed Oct 06 00:53:36 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927028, encodeId=a5af92e02879, content=谢谢分享，很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=39831709355, createdName=秋敏, createdTime=Thu Feb 25 08:52:49 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911032, encodeId=f403911032af, content=临床指导意义重大！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a195447725, createdName=ms9000000471094618, createdTime=Sat Dec 26 09:46:05 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904499, encodeId=33e79044997b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:36:57 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903059, encodeId=322590305925, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201128/8bd43ecc40d747e890c41c35a068882e/9f274b8360b04bf085fc42125c37f102.jpg, createdBy=c4bc5437608, createdName=ms1000001333439432, createdTime=Sat Nov 28 16:18:25 CST 2020, time=2020-11-28, status=1, ipAttribution=)]
    2020-12-26 ms9000000471094618

    临床指导意义重大！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1058002, encodeId=ead1105800209, content=学习收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb85598371, createdName=henghengbobo, createdTime=Wed Oct 06 00:53:36 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927028, encodeId=a5af92e02879, content=谢谢分享，很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=39831709355, createdName=秋敏, createdTime=Thu Feb 25 08:52:49 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911032, encodeId=f403911032af, content=临床指导意义重大！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a195447725, createdName=ms9000000471094618, createdTime=Sat Dec 26 09:46:05 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904499, encodeId=33e79044997b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:36:57 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903059, encodeId=322590305925, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201128/8bd43ecc40d747e890c41c35a068882e/9f274b8360b04bf085fc42125c37f102.jpg, createdBy=c4bc5437608, createdName=ms1000001333439432, createdTime=Sat Nov 28 16:18:25 CST 2020, time=2020-11-28, status=1, ipAttribution=)]
    2020-12-03 12544b9em05暂无昵称

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1058002, encodeId=ead1105800209, content=学习收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb85598371, createdName=henghengbobo, createdTime=Wed Oct 06 00:53:36 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=927028, encodeId=a5af92e02879, content=谢谢分享，很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=39831709355, createdName=秋敏, createdTime=Thu Feb 25 08:52:49 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911032, encodeId=f403911032af, content=临床指导意义重大！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a195447725, createdName=ms9000000471094618, createdTime=Sat Dec 26 09:46:05 CST 2020, time=2020-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=904499, encodeId=33e79044997b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=12544b9em05暂无昵称, createdTime=Thu Dec 03 08:36:57 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903059, encodeId=322590305925, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201128/8bd43ecc40d747e890c41c35a068882e/9f274b8360b04bf085fc42125c37f102.jpg, createdBy=c4bc5437608, createdName=ms1000001333439432, createdTime=Sat Nov 28 16:18:25 CST 2020, time=2020-11-28, status=1, ipAttribution=)]
    2020-11-28 ms1000001333439432

    谢谢分享学习

    0

相关指南

2020 昆士兰临床指南：新型冠状病毒病（COVID-19）产科服务

昆士兰卫生组织(QLD,Queensland Health) · 2020-03-13

美国妇产科医师学会“2017 产科镇痛和麻醉实践指南”解读

暂未更新 · 2017-08-30

妇科、产科、儿科常见病种入出院参考标准和转诊指导原则（试行）

中华医学会(CMA,Chinese Medical Association) · 2017-02-28

2016 ACOG实践简报：产科镇痛和麻醉（No.177）

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2017-04-01

2016 ACOG/SMFM产科护理共识：重症孕产妇发病率筛查和回顾

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2016-09-01

2015 NICE指南：产科安全助产配置(NG4)

暂未更新 · 2015-02-27

拓展阅读

2015 NICE指南：产科安全助产配置(NG4)

暂未更新 · 2015-02-27

2016 ACOG/SMFM产科护理共识：重症孕产妇发病率筛查和回顾

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2016-09-01

2016 ACOG实践简报：产科镇痛和麻醉（No.177）

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2017-04-01

妇科、产科、儿科常见病种入出院参考标准和转诊指导原则（试行）

中华医学会(CMA,Chinese Medical Association) · 2017-02-28

美国妇产科医师学会“2017 产科镇痛和麻醉实践指南”解读

暂未更新 · 2017-08-30

2020 昆士兰临床指南：新型冠状病毒病（COVID-19）产科服务

昆士兰卫生组织(QLD,Queensland Health) · 2020-03-13